ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,973.78
-0.16%
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs Yen
155.675
0.00%
Brent Oil
83.76
0.00%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. イギリス
  5. LSE
  6. Hemogenyx Pharmaceuticals Plc (HEMO)

  7. Hemogenyx Pharmaceuticals Plc (HEMO) ニュース

HEMO

Hemogenyx Pharmaceuticals (HEMO)

Hemogenyx Pharmaceuticals Plc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:LSE:HEMO
日付受信時刻ニュースソース見出しコード企業名
2024/04/2520 : 19Alliance NewsAlliance NewsEARNINGS: LSL starts 2024 "strongly"; Focusrite maintains payoutLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/04/2515 : 00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Final ResultsLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/03/2816 : 00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Total Voting RightsLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/2923 : 04Alliance NewsAlliance NewsHemogenyx Pharmaceuticals raises money for leukaemia treatmentLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/2916 : 00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Placing to Raise US$4.2 millionLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/1620 : 27Alliance NewsAlliance NewsHemogenyx shares rise on potential for CBR to treat brain diseasesLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/1616 : 00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC CBR Brain DeliveryLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/1419 : 14Alliance NewsAlliance NewsHemogenyx says CBR can be used intranasally to treat viral infectionsLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/1416 : 00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC CBR Intranasal DeliveryLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/0919 : 00Alliance NewsAlliance NewsIN BRIEF: Hemogenyx shares surge as FDA lifts Hemo-Car-T trial holdLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/0916 : 00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC FDA Consents to Phase I Trials of HEMO-CAR-TLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/0219 : 44Alliance NewsAlliance NewsIN BRIEF: Hemogenyx hails US patent application progressLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/0216 : 00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Approval and Issuance of U.S. Conditioning PatentLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/01/1620 : 13Alliance NewsAlliance NewsHemogenyx Pharmaceuticals sends complete response on HEMO-CAR-T to FDALSE:HEMOHemogenyx Pharmaceuticals Plc
2024/01/1616 : 00UK RegulatoryHemogenyx Pharmaceuticals PLC Submission of Complete Response to Clinical HoldLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/01/0819 : 56Alliance NewsAlliance NewsHemogenyx Pharmaceuticals completes process qualification runLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/01/0816 : 00UK RegulatoryHemogenyx Pharmaceuticals PLC HEMO-CAR-T Process Qualification Run CompletedLSE:HEMOHemogenyx Pharmaceuticals Plc
2023/11/2901 : 53Alliance NewsAlliance NewsTRADING UPDATES: Upland Resources completes technical study at SarawakLSE:HEMOHemogenyx Pharmaceuticals Plc
2023/11/2821 : 19UK RegulatoryHemogenyx Pharmaceuticals PLC Placing to Raise GBP534,375LSE:HEMOHemogenyx Pharmaceuticals Plc
2023/11/2719 : 52Alliance NewsAlliance NewsHemogenyx shares up as says CBR platform a potential cancer treatmentLSE:HEMOHemogenyx Pharmaceuticals Plc
2023/11/2716 : 00UK RegulatoryHemogenyx Pharmaceuticals PLC CBR Expanded to Treatment of CancerLSE:HEMOHemogenyx Pharmaceuticals Plc
2023/11/1600 : 43Alliance NewsAlliance NewsHemogenyx Pharmaceuticals completes lentivirus re-manufactureLSE:HEMOHemogenyx Pharmaceuticals Plc
2023/11/1516 : 00UK RegulatoryHemogenyx Pharmaceuticals PLC Lentivirus Re-manufacturing CompletedLSE:HEMOHemogenyx Pharmaceuticals Plc
2023/10/3116 : 00UK RegulatoryHemogenyx Pharmaceuticals PLC Total Voting RightsLSE:HEMOHemogenyx Pharmaceuticals Plc
2023/09/2822 : 24Alliance NewsAlliance NewsEARNINGS: Dar Global profit multiplies, Hemogenyx loss widensLSE:HEMOHemogenyx Pharmaceuticals Plc
2023/09/2820 : 28UK RegulatoryHemogenyx Pharmaceuticals PLC Half-year ReportLSE:HEMOHemogenyx Pharmaceuticals Plc
2023/09/1822 : 37Alliance NewsAlliance NewsTRADING UPDATES: Avingtrans buys Adaptix, TPXimpact sells QuestersLSE:HEMOHemogenyx Pharmaceuticals Plc
2023/09/1815 : 00UK RegulatoryHemogenyx Pharmaceuticals PLC Strategic Investment from Prevail Partners, LLCLSE:HEMOHemogenyx Pharmaceuticals Plc
2023/09/1422 : 31Alliance NewsAlliance NewsHemogenyx Pharma says US FDA accepts Hemo-Car-T clinical hold lift planLSE:HEMOHemogenyx Pharmaceuticals Plc
2023/09/1417 : 11Dow Jones NewsHemogenyx Pharmaceuticals Says FDA Accepted Plans to Address Leukemia Treatment ConcernsLSE:HEMOHemogenyx Pharmaceuticals Plc
 Showing the most relevant articles for your search:LSE:HEMO

最近閲覧した銘柄

LSE
0H77
Comstage Stoxx Europe 60...
ASX
MTHNB
Mithril Resources
ASX
AAO
Australasia Gold
NASDAQ
AAXHCXX
Jpmorgan Chase Financial...
BIT
UC929F
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有